Literature DB >> 8120517

Resting venous plasma adrenalin in 70-year-old men correlated positively to survival in a population study: the significance of the physical working capacity.

N J Christensen1, K Schultz-Larsen.   

Abstract

OBJECTIVE: The aim of the study was to evaluate plasma noradrenaline (NA) and plasma adrenalin (A) as predictors of mortality in a population study.
SUBJECTS: All subjects were 70 years of age in 1984. They were selected from the National Person Register. Altogether, 804 subjects participated in a comprehensive medical examination.
INTERVENTIONS: Plasma NA and A were measured in blood samples collected after the subjects had rested in the supine position for 15 min. The subjects have now been followed for 7 years. MAIN OUTCOME MEASURES: Seven years later, 115 men and 63 women had died.
RESULTS: Cox regression analysis showed that the mortality in the male group was positively correlated to plasma NA (P < 0.002) and inversely correlated to forced vital capacity (P < 0.0000) and plasma A (P < 0.02). A positive correlation was obtained between physical working capacity and plasma A. When an index of physical working capacity was included in the Cox regression analysis, both plasma NA and plasma A became insignificant, whereas a strong positive correlation appeared between physical working capacity and survival (P < 0.0000). Those who had low plasma A values in 1984 tended to die from cardiovascular diseases in the follow-up period, whereas in those who died from cancer, plasma A values were similar to those of the general population.
CONCLUSIONS: Subjects with high plasma A values had the best survival rate during the 7 year follow-up period, probably because they also had the best physical working capacity. High plasma NA values, as expected, were associated with a reduced survival rate. Measurements of physical working capacity may be an inexpensive measure of probable survival in 70-year-old subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120517     DOI: 10.1111/j.1365-2796.1994.tb01064.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Biomarkers of Psychological Stress in Health Disparities Research.

Authors:  Zora Djuric; Chloe E Bird; Alice Furumoto-Dawson; Garth H Rauscher; Mack T Ruffin; Raymond P Stowe; Katherine L Tucker; Christopher M Masi
Journal:  Open Biomark J       Date:  2008-01-01

Review 2.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

3.  Plasma catecholamines: follow-up on 10-year study in health and cardiovascular disease.

Authors:  P Prikryl; G Cornélissen; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

4.  Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle.

Authors:  Jennifer L Gordon; Susan S Girdler
Journal:  Psychophysiology       Date:  2014-01-08       Impact factor: 4.016

5.  Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.

Authors:  L Forslund; I Björkander; M Ericson; C Held; T Kahan; N Rehnqvist; P Hjemdahl
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

6.  Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress.

Authors:  T Hamazaki; S Sawazaki; T Nagasawa; Y Nagao; Y Kanagawa; K Yazawa
Journal:  Lipids       Date:  1999       Impact factor: 1.880

7.  Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study.

Authors:  Christian Otte; Thomas C Neylan; Sharon S Pipkin; Warren S Browner; Mary A Whooley
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

8.  Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women.

Authors:  A R Saxena; B Chamarthi; G H Williams; P N Hopkins; E W Seely
Journal:  J Hum Hypertens       Date:  2013-11-14       Impact factor: 3.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.